CRDF Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.80%

Insider Buying (Last 12 Months): $910,299.00

Insider Selling (Last 12 Months): $0.00

Cardiff Oncology Insider Trading History Chart

Cardiff Oncology Share Price & Price History

^$3.05

▼ -0.086 (-2.74%)

As of 04/1/2025 04:48 PM ET

Days: 30 | 90 | 365

Cardiff Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/11/2024	Gary W. Pace	Director	Buy	350,115	$2.60	$910,299.00	1,047,876
12/19/2023	Gary W. Pace	Director	Buy	30,000	$1.37	$41,100.00	697,761
11/25/2022	Mark Erlander	CEO	Buy	10,000	$1.43	$14,300.00	24,481
9/19/2022	Lale White	Director	Buy	15,000	$1.64	$24,600.00	113,788
9/16/2022	James E. Levine	CFO	Buy	30,000	$1.56	$46,800.00	60,000
9/15/2022	Renee P Tannenbaum	Director	Buy	10,000	$1.72	$17,200.00	10,000

SEC Filings (Institutional Ownership Changes) for Cardiff Oncology (NASDAQ:CRDF)

16.29% of Cardiff Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cardiff Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/19/2025	Invst LLC	36,000	$0.16M	0.0%	+60.0%	0.070%
2/19/2025	Parr Mcknight Wealth Management Group LLC	16,000	$69K	0.0%	N/A	0.031%
2/18/2025	AWM Investment Company Inc.	106,435	$0.46M	0.1%	N/A	0.208%
2/17/2025	Two Sigma Advisers LP	14,800	$64K	0.0%	-95.5%	0.029%
2/17/2025	Two Sigma Investments LP	105,227	$0.46M	0.0%	-43.0%	0.206%
2/17/2025	Shay Capital LLC	20,862	$91K	0.0%	N/A	0.041%
2/17/2025	Point72 Asset Management L.P.	508,438	$2.21M	0.0%	N/A	0.994%
2/17/2025	ProShare Advisors LLC	11,486	$50K	0.0%	N/A	0.022%
2/17/2025	Nuveen Asset Management LLC	586,616	$2.55M	0.0%	+73.7%	1.147%
2/17/2025	Orbimed Advisors LLC	1,538,462	$6.68M	0.1%	N/A	3.009%
2/17/2025	Millennium Management LLC	440,944	$1.91M	0.0%	+188.8%	0.862%
2/17/2025	Laurion Capital Management LP	576,924	$2.50M	0.0%	N/A	1.128%
2/17/2025	J. Goldman & Co LP	47,250	$0.21M	0.0%	N/A	0.092%
2/17/2025	Jacobs Levy Equity Management Inc.	139,854	$0.61M	0.0%	N/A	0.274%
2/17/2025	Deutsche Bank AG	49,566	$0.22M	0.0%	N/A	0.097%
2/17/2025	Blackstone Inc.	41,700	$0.18M	0.0%	N/A	0.082%
2/17/2025	Caxton Corp	13,287	$58K	0.3%	N/A	0.026%
2/17/2025	Bank of America Corp DE	34,012	$0.15M	0.0%	-25.0%	0.067%
2/17/2025	BNP Paribas Financial Markets	5,733	$25K	0.0%	N/A	0.011%
2/17/2025	Acorn Capital Advisors LLC	1,442,308	$6.26M	3.4%	N/A	2.821%
2/14/2025	Northern Trust Corp	337,092	$1.46M	0.0%	+8.9%	0.659%
2/14/2025	The Manufacturers Life Insurance Company	15,487	$67K	0.0%	N/A	0.030%
2/14/2025	Boothbay Fund Management LLC	129,960	$0.56M	0.0%	N/A	0.254%
2/14/2025	Voya Investment Management LLC	13,124	$57K	0.0%	N/A	0.026%
2/14/2025	Adage Capital Partners GP L.L.C.	1,292,308	$5.61M	0.0%	N/A	2.527%
2/14/2025	Price T Rowe Associates Inc. MD	15,390	$67K	0.0%	-68.7%	0.030%
2/14/2025	MetLife Investment Management LLC	26,559	$0.12M	0.0%	N/A	0.052%
2/13/2025	Marshall Wace LLP	62,600	$0.27M	0.0%	-56.2%	0.122%
2/13/2025	Elkhorn Partners Limited Partnership	32,000	$0.14M	0.1%	-28.9%	0.063%
2/13/2025	XTX Topco Ltd	40,763	$0.18M	0.0%	-66.1%	0.080%
2/13/2025	Mariner LLC	14,047	$61K	0.0%	N/A	0.027%
2/13/2025	Barclays PLC	62,596	$0.27M	0.0%	+17.9%	0.122%
2/13/2025	DRW Securities LLC	23,474	$0.10M	0.0%	N/A	0.046%
2/13/2025	Raymond James Financial Inc.	12,996	$56K	0.0%	N/A	0.025%
2/13/2025	Renaissance Technologies LLC	483,090	$2.10M	0.0%	-19.8%	0.945%
2/13/2025	Wells Fargo & Company MN	32,064	$0.14M	0.0%	+38.1%	0.063%
2/12/2025	Thoroughbred Financial Services LLC	19,614	$85K	0.0%	+43.8%	0.038%
2/12/2025	Geode Capital Management LLC	982,878	$4.27M	0.0%	+5.9%	1.922%
2/12/2025	Blair William & Co. IL	282,025	$1.22M	0.0%	+14.1%	0.552%
2/11/2025	American Century Companies Inc.	53,955	$0.23M	0.0%	+12.8%	0.106%
2/11/2025	Virtu Financial LLC	51,181	$0.22M	0.0%	N/A	0.100%
2/11/2025	Intech Investment Management LLC	18,266	$79K	0.0%	N/A	0.036%
2/10/2025	Glenview Trust co	23,978	$0.10M	0.0%	N/A	0.047%
2/7/2025	HighTower Advisors LLC	34,213	$0.15M	0.0%	+123.1%	0.067%
2/6/2025	Raymond James Financial Inc.	12,996	$56K	0.0%	N/A	0.025%
2/6/2025	Charles Schwab Investment Management Inc.	101,664	$0.44M	0.0%	-16.2%	0.199%
2/4/2025	Bank of New York Mellon Corp	288,615	$1.25M	0.0%	+68.7%	0.564%
2/3/2025	Callan Capital LLC	101,575	$0.44M	0.0%	+11.1%	0.199%
1/30/2025	Rhumbline Advisers	53,172	$0.23M	0.0%	+24.0%	0.104%
1/17/2025	SG Americas Securities LLC	17,834	$77K	0.0%	-25.5%	0.035%
1/15/2025	HB Wealth Management LLC	24,500	$0.11M	0.0%	N/A	0.048%
1/14/2025	Assenagon Asset Management S.A.	67,231	$0.29M	0.0%	-75.1%	0.131%
11/19/2024	Barclays PLC	53,089	$0.14M	0.0%	+291.9%	0.104%
11/19/2024	Invst LLC	22,500	$60K	0.0%	-37.5%	0.044%
11/16/2024	Geode Capital Management LLC	928,232	$2.48M	0.0%	+1.9%	1.815%
11/15/2024	Barclays PLC	53,089	$0.14M	0.0%	+291.9%	0.104%
11/15/2024	XTX Topco Ltd	120,384	$0.32M	0.0%	+44.3%	0.235%
11/15/2024	Jane Street Group LLC	43,998	$0.12M	0.0%	-59.1%	0.086%
11/15/2024	State Street Corp	832,652	$2.22M	0.0%	+3.4%	1.628%
11/12/2024	Charles Schwab Investment Management Inc.	121,293	$0.32M	0.0%	+11.5%	0.261%
11/7/2024	MAI Capital Management	663,363	$1.77M	0.0%	+0.7%	1.425%
11/5/2024	GSA Capital Partners LLP	186,650	$0.50M	0.0%	+432.7%	0.401%
10/23/2024	Assenagon Asset Management S.A.	270,523	$0.72M	0.0%	-77.8%	0.605%
10/3/2024	SG Americas Securities LLC	23,937	$64K	0.0%	N/A	0.054%
9/16/2024	Point72 DIFC Ltd	12,284	$27K	0.0%	N/A	0.026%
9/16/2024	Cubist Systematic Strategies LLC	68,730	$0.15M	0.0%	+112.9%	0.148%
8/16/2024	Invst LLC	36,000	$74K	0.0%	N/A	0.077%
8/14/2024	Cubist Systematic Strategies LLC	68,730	$0.15M	0.0%	+112.9%	0.154%
8/14/2024	Point72 DIFC Ltd	12,284	$27K	0.0%	N/A	0.027%
8/14/2024	Marshall Wace LLP	298,829	$0.66M	0.0%	-31.2%	0.668%
8/12/2024	XTX Topco Ltd	83,437	$0.19M	0.0%	N/A	0.187%
8/12/2024	Blair William & Co. IL	227,630	$0.51M	0.0%	+32.2%	0.489%
8/9/2024	Renaissance Technologies LLC	157,490	$0.35M	0.0%	+82.9%	0.352%
8/9/2024	Dimensional Fund Advisors LP	19,098	$42K	0.0%	+34.4%	0.043%
8/8/2024	Thoroughbred Financial Services LLC	52,375	$0.12M	0.0%	N/A	0.117%
8/8/2024	American Century Companies Inc.	45,360	$0.10M	0.0%	+98.7%	0.101%
8/8/2024	Ground Swell Capital LLC	17,098	$38K	0.0%	N/A	0.038%
8/1/2024	Rhumbline Advisers	45,993	$0.10M	0.0%	N/A	0.103%
7/26/2024	Bank of New York Mellon Corp	115,304	$0.26M	0.0%	N/A	0.258%
7/18/2024	Assenagon Asset Management S.A.	1,215,922	$2.70M	0.0%	+380.6%	2.719%
5/16/2024	Elkhorn Partners Limited Partnership	39,000	$0.21M	0.1%	-40.5%	0.087%
5/10/2024	Vanguard Group Inc.	1,921,257	$10.26M	0.0%	+0.5%	4.296%
5/9/2024	Blair William & Co. IL	172,180	$0.92M	0.0%	+32.4%	0.385%
5/3/2024	Callan Capital LLC	42,747	$0.23M	0.0%	+37.2%	0.096%
4/24/2024	Assenagon Asset Management S.A.	252,982	$1.35M	0.0%	N/A	0.566%
4/22/2024	PFG Investments LLC	10,001	$53K	0.0%	N/A	0.022%
11/6/2023	Callan Capital LLC	31,147	$43K	0.0%	+129.2%	0.070%
11/6/2023	Assenagon Asset Management S.A.	84,272	$0.12M	0.0%	-40.8%	0.189%
7/25/2023	Assenagon Asset Management S.A.	142,428	$0.21M	0.0%	-63.9%	0.319%
7/21/2023	Creative Planning	57,750	$85K	0.0%	+135.7%	0.129%
5/4/2023	Denver Wealth Management Inc.	18,235	$30K	0.0%	N/A	0.041%
4/18/2023	Assenagon Asset Management S.A.	394,994	$0.65M	0.0%	+120.0%	0.884%
2/13/2023	GSA Capital Partners LLP	352,186	$0.49M	0.1%	+198.8%	0.788%
2/10/2023	Blair William & Co. IL	151,575	$0.21M	0.0%	-10.6%	0.339%
2/1/2023	Bank of Montreal Can	98,600	$0.14M	0.0%	N/A	0.221%
1/12/2023	Assenagon Asset Management S.A.	179,543	$0.25M	0.0%	+7.8%	0.402%
11/8/2022	Atom Investors LP	18,298	$28K	0.0%	-45.9%	0.041%
11/7/2022	Virtu Financial LLC	34,311	$53K	0.0%	+173.1%	0.079%
11/3/2022	Creative Planning	25,575	$39K	0.0%	N/A	0.059%
10/27/2022	Assenagon Asset Management S.A.	166,534	$0.26M	0.0%	+7.3%	0.385%

Data available starting January 2016

See Full Table

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops novel therapies to treat various cancers in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor to treatment a range of solid tumor cancers and KRAS/NRAS-mutated metastatic colorectal and metastatic pancreatic cancer, as well as investigator-initiated trials in triple negative breast cancer and small cell lung cancer; and TROV-054 is a Phase 1b/2 for FOLFIRI and bevacizumab. The company primarily serves pharmaceutical manufacturers. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2012. Cardiff Oncology, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

Today's Range

Now: $3.05

$2.94

$3.13

50 Day Range

MA: $3.99

$3.14

$4.77

52 Week Range

Now: $3.05

$2.01

$6.38

Volume

1,231,761 shs

Average Volume

1,102,763 shs

Market Capitalization

$203.16 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Who are the company insiders with the largest holdings of Cardiff Oncology?: Cardiff Oncology's top insider shareholders include:
Gary W Pace (Director)
Learn More about top insider investors at Cardiff Oncology.